Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMED · against 225 other Healthcare companies of similar size
Ranked #88 of 226 · scores higher than 61% of peers · safety percentile 60
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)29 peers with a safety percentile of 50–59, including MMED · Click a bar to see the companies
A mix: stronger debt / equity, but weaker current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 218 reported | 0.02× | 0.25× | 87% | 33% | |
| BetaLower is better · 225 reported | Not reported | 0.54 | — | — | 33% |
| Current ratioHigher is better · 217 reported | 1.81× | 2.76× | 30% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 3.1B EUR (≈$3.4B) | 99 | 100 | |
| 5 | 9.0B USD | 98 | 51 | |
| 84 | 22.0B CNY (≈$3.1B) | 63 | 67 | |
| 85 | 70.9B ZAR (≈$3.9B) | 61 | 48 | |
| 86 | 3.4B USD | 61 | 48 | |
| 87 | 5.76T KRW (≈$4.1B) | 61 | 59 | |
| 88 | 5.3B USD | 60 | 50 | |
| 89 | 34.2B CNY (≈$4.8B) | 60 | 59 | |
| 90 | 3.5B USD | 59 | 75 | |
| 91 | 3.2B USD | 59 | 65 | |
| 92 | 3.4B USD | 58 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score